ask="5.70"
ask_size="1600"
average_daily_volume="790231"
bid="3.65"
bid_size="500"
book_value="5.03"
change="-0.04"
change_from_200_day_moving_average="1.07"
change_from_50_day_moving_average="0.36"
change_from_52_week_high="-11.10"
change_From_52_week_low="2.55"
change_in_percent="-0.94%"
close="4.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.22"
ebitda="-104.38M"
eps_estimate_current_year="-9.70"
eps_estimate_next_quarter="-0.84"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="9594000"
high="4.28"
high_52_weeks="15.30"
last_trade_date="2/22/2017"
last_trade_price="4.20"
last_trade_size="2430"
last_trade_time="4:00pm"
low="4.11"
low_52_weeks="1.65"
market_capitalization="61.26M"
moving_average_200_day="3.13"
moving_average_50_day="3.84"
name="Orexigen Therapeutics
Inc."
notes="N/A"
one_year_target_price="11.67"
open="4.20"
pe_ratio="N/A"
peg_ratio="0.01"
percent_change_from_200_day_moving_average="+34.20%"
percent_change_from_50_day_moving_average="+9.35%"
percent_change_from_52_week_high="-72.55%"
percent_change_from_52_week_low="+154.55%"
previous_close="4.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.84"
price_per_sales="2.50"
revenue="24.76M"
shares_outstanding="14586000"
short_ratio="2.03"
stock_exchange="NMS"
symbol="OREX"
volume="209068"
weeks_range_52="1.65 - 15.30"
